Baxter International Inc.

BAX - Financial Snapshot

Healthcare sector | Medical Instruments & Supplies industry

View on:
Ranks:

Metrics for BAX

Price $19.91
Shares Outstanding 514.06M
All-Time Low $2.90
52-Week Low $17.40

Balance Statement Metrics

Net Cash / Share $0
cashValuePerShare = (Cash + Short Term Investments - Total Liabilities) / Shares Outstanding
⇒ cashValuePerShare = ((1,726,000,000 - 13,853,000,000) / 514,055,805) = -23.5908
Net Current Assets / Share $-13.46
netCurrentAssetsPerShare = (Current Assets - Total Liabilities) / Shares Outstanding
⇒ netCurrentAssetsPerShare = ((6,933,000,000 - 13,853,000,000) / 514,055,805) = -13.4616
Net Tangible Assets / Share $0
netTangibleAssetsPerShare = (Total Assets - Intangibles - Total Liabilities) / Shares Outstanding
⇒ netTangibleAssetsPerShare = ((21,067,000,000 - 10,205,000,000 - 13,853,000,000) / 514,055,805) = -5.82

Income Metrics

Max Earning Power / Share $7.89
maxEarningPowerPerShare = (EBITDA / EP_MULTIPLIER) / Shares Outstanding
⇒ maxEarningPowerPerShare = ((426,000,000 / 0.105) / 514,055,805) = 7.8924
Adjusted Earning Power $-0.85
adjustedEarningPower = (Net Income / EP_MULTIPLIER) / Shares Outstanding
⇒ adjustedEarningPower = ((-46,000,000 / 0.105) / 514,055,805) = -0.8522
Non-Cash Charges to Market Cap 2.32%
nonCashChargeToMKTCAP = Non-Cash Charges / Market Capitalization
Data as of: Price 02-03-26 16:00 ET, Balance Sheet 2025-09-30, Income Statement 2025-09-30, Cash Flow 2025-09-30

Indicators

Dividend indicators Value Date
Pays Dividend Yes 2-3-2026
Dividend Type common 2-3-2026
Dividend Payout / Share $0.17 2-3-2026
Last Dividend Date 1-1-26
Income indicators Value Date
EBITDA Positive Yes 2-3-2026
Net Income Positive No 2-3-2026

Shares Outstanding Changes

Date Shares Outstanding Delta
No recent share changes

Short Interest Changes

Latest short interest: 33,761,661 shares (9.88% of float) | Days to cover: 3.97

Date Short Interest Delta Δ %
2026-02-03 33,761,661 shares +0 +0.00%
2026-02-02 33,761,661 shares +0 +0.00%
2026-01-30 33,761,661 shares None —

Interesting Volume Days

Volume/ratio use shares outstanding as of the event date (frozen).

Date Volume Shares Outstanding Volume / Shares Price
No interesting volume events

Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; administrative sets; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories. The company also provides specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, kidney dialysis centers, and patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. It has an agreement with Celerity Pharmaceuticals, LLC to develop acute care generic injectable premix and oncolytic products. The company operates in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.